AsclepiX Therapeutics
PRIVATE
STATUS
Later Stage VC
LATEST DEAL TYPE
$5M
LATEST DEAL AMOUNT
12
INVESTORS
Description
Provider of biomimetic anti-angiogenic and anti-lymphangiogenic peptides created to treat ocular diseases. The company develops biomimetic anti-angiogenic and anti-lymphangiogenic peptides for indications in ophthalmology, oncology and for other angiogenesi and lymphangiogenesis-dependent diseases enabling patients and doctors to better treat ocular ailments.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Other Pharmaceuticals and Biotechnology
Primary Office
- 301 West 29th Street
- Baltimore, MD 21211
- United States
+1 (410) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore AsclepiX Therapeutics’s full profile, request a free trial.
AsclepiX Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 17-Jun-2019 | $5M | 00.00 | Completed | Generating Revenue | |
| 6. Grant | 01-Jan-2017 | 00.000 | 00000 | Completed | Generating Revenue | |
| 5. Convertible Debt | 20-Jul-2016 | 00000 | 00000 | Completed | Generating Revenue | |
| 4. Grant | 01-Sep-2015 | 00000 | Completed | Generating Revenue | ||
| 3. Grant | 24-Jul-2014 | 00.000 | Completed | Generating Revenue | ||
| 2. Accelerator/Incubator | 25-Jun-2014 | Completed | Generating Revenue | |||
| 1. Grant | 15-Jun-2013 | $100K | Completed | Generating Revenue |
AsclepiX Therapeutics Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Barer & Son Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Piedmont Capital Partners | Merchant Banking Firm | Minority | 000 0000 | 000000 0 | ||
| Rapha Capital Management | Corporation | Minority | 000 0000 | 000000 0 | ||
| Salem Partners | Investment Bank | Minority | 000 0000 | 000000 0 | ||
| TCP Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
AsclepiX Therapeutics Executive Team (3)
AsclepiX Therapeutics Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Wendy Perrow | AsclepiX Therapeutics | Chief Executive Officer & Board Member | 000 0000 |